Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label side effects. Show all posts
Showing posts with label side effects. Show all posts

Monday, April 15, 2019

25 Most Common Stroke Side Effects and Treatments from Flint Rehab

You can tell how competent your doctor is if s/he covers all this on their own, it is their responsibility to know and disseminate this to you. OR you have to find this on your own. I have a few minor quibbles in here but it is good, at least as far as guidelines go. I still expect protocols but that won't occur until stroke survivors run things in stroke.   I had to learn everything in here myself since my doctor told me nothing about how recovery would go. He knew nothing and obviously was never going to to know anything in his 20 plus years there.

25 Most Common Stroke Side Effects and Treatments from Flint Rehab

Wednesday, April 3, 2019

Elite Hospitals Plunge Into Unproven Stem Cell Treatments

I haven't seen any true sign yet that stem cells work for stroke. But these side effects have occurred;

Tumors caused by pluripotent stem cells can be tackled with radiation, say Stanford researchers

 

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

 

He went abroad for stem cell treatment. Now he’s a cautionary tale. Stroke patient Jim Gass

 

“Off-the-charts dangerous”: Sham stem cell trial at Florida clinic blinds three women

 

Stem cell propagation fuels cancer risk in different organs 

Elite Hospitals Plunge Into Unproven Stem Cell Treatments

The online video seems to promise everything an arthritis patient could want.
The six-minute segment mimics a morning talk show, using a polished TV host to interview guests around a coffee table. Dr. Adam Pourcho extols the benefits of stem cells and “regenerative medicine” for healing joints without surgery. Pourcho, a sports medicine specialist, says he has used platelet injections to treat his own knee pain, as well as a tendon injury in his elbow. Extending his arm, he says, “It’s completely healed.”
Brendan Hyland, a gym teacher and track coach, describes withstanding intense heel pain for 18 months before seeing Pourcho. Four months after the injections, he says, he was pain-free and has since gone on a 40-mile hike.
“I don’t have any pain that stops me from doing anything I want,” Hyland says.
The video’s cheerleading tone mimics the infomercials used to promote stem cell clinics, several of which have recently gotten into hot water with federal regulators, said Dr. Paul Knoepfler, a professor of cell biology and human anatomy at the University of California-Davis School of Medicine. But the marketing video wasn’t filmed by a little-known operator.
It was sponsored by Swedish Medical Center, the largest nonprofit health provider in the Seattle area.
Swedish is one of a growing number of respected hospitals and health systems — including the Mayo Clinic, the Cleveland Clinic and the University of Miami — that have entered the lucrative business of stem cells and related therapies, including platelet injections. Typical treatments involve injecting patients’ joints with their own fat or bone marrow cells, or with extracts of platelets, the cell fragments known for their role in clotting blood. Many patients seek out regenerative medicine to stave off surgery, even though the evidence supporting these experimental therapies is thin at best, Knoepfler said.
Hospitals say they’re providing options to patients who have exhausted standard treatments. But critics suggest the hospitals are exploiting desperate patients and profiting from trendy but unproven treatments.
The Food and Drug Administration is attempting to shut down clinics that hawk unapproved stem cell therapies, which have been linked to several cases of blindness and at least 12 serious infections. Although doctors usually need preapproval to treat patients with human cells, the FDA has carved out a handful of exceptions, as long as the cells meet certain criteria, said Barbara Binzak Blumenfeld, an attorney who specializes in food and drug law at Buchanan Ingersoll & Rooney in Washington.
Hospitals like Mayo are careful to follow these criteria, to avoid running afoul of the FDA, said Dr. Shane Shapiro, program director for the Regenerative Medicine Therapeutics Suites at Mayo Clinic’s campus in Florida.


‘Expensive Placebos’
While hospital-based stem cell treatments may be legal, there’s no strong evidence they work, said Leigh Turner, an associate professor at the University of Minnesota’s Center for Bioethics who has published a series of articles describing the size and dynamics of the stem cell market. 
“FDA approval isn’t needed and physicians can claim they aren’t violating federal regulations,” Turner said. “But just because something is legal doesn’t make it ethical.”
For doctors and hospitals, stem cells are easy money, Turner said. Patients typically pay more than $700 a treatment for platelets and up to $5,000 for fat and bone marrow injections. As a bonus, doctors don’t have to wrangle with insurance companies, which view the procedures as experimental and largely don’t cover them.
“It’s an out-of-pocket, cash-on-the-barrel economy,” Turner said. Across the country, “clinicians at elite medical facilities are lining their pockets by providing expensive placebos.”
Some patient advocates worry that hospitals are more interested in capturing a slice of the stem-cell market than in proving their treatments actually work.
“It’s lucrative. It’s easy to do. All these reputable institutions, they don’t want to miss out on the business,” said Dr. James Rickert, president of the Society for Patient Centered Orthopedics, which advocates for high-quality care. “It preys on people’s desperation.”
In a joint statement, Pourcho and Swedish defended the online video.
“The terminology was kept simple and with analogies that the lay person would understand,” according to the statement. “As with any treatment that we provide, we encourage patients to research and consider all potential treatment options before deciding on what is best for them.”
But Knoepfler said the guests on the video make several “unbelievable” claims.
At one point, Dr. Pourcho says that platelets release growth factors that tell the brain which types of stem cells to send to the site of an injury. According to Pourcho, these instructions make sure that tissues are repaired with the appropriate type of cell, and “so you don’t get, say, eyeball in your hand.”
Knoepfler, who has studied stem cell biology for two decades, said he has never heard of “any possibility of growing eyeball or other random tissues in your hand.” Knoepfler, who wrote about the video in February on his blog, The Niche, said, “There’s no way that the adult brain could send that kind of stem cells anywhere in the body.”
The marketing video debuted in July on KING-TV, a Seattle station, as part of a local lifestyles show called “New Day Northwest.” Although much of the show is produced by the KING 5 news team, some segments — like Pourcho’s interview — are sponsored by local advertisers, said Jim Rose, president and general manager of KING 5 Media Group.
After being contacted by KHN, Rose asked Swedish to remove the video from YouTube because it wasn’t labeled as sponsored content. Omitting that label could allow the video to be confused with news programming. The video now appears only on the KING-TV website, where Swedish is labeled as the sponsor.
“The goal is to clearly inform viewers of paid content so they can distinguish editorial and news content from paid material,” Rose said. “We value the public’s trust.”
Increasing Scrutiny
Federal authorities have recently begun cracking down on doctors who make unproven claims or sell unapproved stem cell products.
In October, the Federal Trade Commission fined stem cell clinics millions of dollars for deceptive advertising, noting that the companies claimed to be able to treat or cure autism, Parkinson’s disease and other serious diseases.
In a recent interview Scott Gottlieb, the FDA commissioner, said the agency will continue to go after what he called “bad actors.”
With more than 700 stem cell clinics in operation, the FDA is first targeting those posing the biggest threat, such as doctors who inject stem cells directly into the eye or brain.
“There are clearly bad actors who are well over the line and who are creating significant risks for patients,” Gottlieb said.
Gottlieb, set to leave office April 5, said he’s also concerned about the financial exploitation of patients in pain.
“There’s economic harm here, where products are being promoted that aren’t providing any proven benefits and where patients are paying out-of-pocket,” Gottlieb said.
Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said there is a broad “spectrum” of stem cell providers, ranging from university scientists leading rigorous clinical trials to doctors who promise stem cells are “for just about anything.” Hospitals operate somewhere in the middle, Marks said.
“The good news is that they’re somewhat closer to the most rigorous academics,” he said.
The Mayo Clinic’s regenerative medicine program, for example, focuses conditions such as arthritis, where injections pose few serious risks, even if that’s not yet the standard of care, Shapiro said.
Rickert said it’s easy to see why hospitals are eager to get in the game.
The market for arthritis treatment is huge and growing. At least 30 million Americans have the most common form of arthritis, with diagnoses expected to soar as the population ages. Platelet injections for arthritis generated more than $93 million in revenue in 2015, according to an article last year in The Journal of Knee Surgery.
“We have patients in our offices demanding these treatments,” Shapiro said. “If they don’t get them from us, they will get them somewhere else.”
Doctors at the Mayo Clinic try to provide stem cell treatments and similar therapies responsibly, Shapiro said. In a paper published this year, Shapiro described the hospital’s consultation service, in which doctors explain patients’ options and clear up misconceptions about what stem cells and other injections can do. Doctors can refer patients to treatment or clinical trials.
“Most of the patients do not get a regenerative [stem cell] procedure,” Shapiro said. “They don’t get it because after we have a frank conversation, they decide, ‘Maybe it’s not for me.’”
Lots Of Hype, Little Proof
Although some hospitals boast of high success rates for their stem cell procedures, published research often paints a different story.
The Mayo Clinic website says that 40 to 70% of patients “find some level of pain relief.” Atlanta-based Emory Healthcare claims that 75 to 80% of patients “have had significant pain relief and improved function.” In the Swedish video, Pourcho claims “we can treat really any tendon or any joint” with PRP.
The strongest evidence for PRP is in pain relief for arthritic knees and tennis elbow, where it appears to be safe and perhaps helpful, said Dr. Nicolas Piuzzi, an orthopedic surgeon at the Cleveland Clinic.
But PRP hasn’t been proven to help every part of the body, he said.
PRP has been linked to serious complications when injected to treat patellar tendinitis, an injury to the tendon connecting the kneecap to the shinbone. In a 2013 paper, researchers described the cases of three patients whose pain got dramatically worse after PRP injections. One patient lost bone and underwent surgery to repair the damage.
“People will say, ‘If you inject PRP, you will return to sports faster,’” said Dr. Freddie Fu, chairman of orthopedic surgery at the University of Pittsburgh Medical Center. “But that hasn’t been proven.”
A 2017 study of PRP found it relieved knee pain slightly better than injections of hyaluronic acid. But that’s nothing to brag about, Rickert said, given that hyaluronic acid therapy doesn’t work, either. While some PRP studies have shown more positive results, Rickert notes that most were so small or poorly designed that their results aren’t reliable.
In its 2013 guidelines for knee arthritis, the American Academy of Orthopaedic Surgeons said it is “unable to recommend for or against” PRP.
“PRP is sort of a ‘buyer beware’ situation,” said Dr. William Li, president and CEO of the Angiogenesis Foundation, whose research focuses on blood vessel formation. “It’s the poor man’s approach to biotechnology.”
Tests of other stem cell injections also have failed to live up to expectations.
Shapiro published a rigorously designed study last year in Cartilage, a medical journal, that found bone marrow injections were no better at relieving knee pain than saltwater injections. Rickert noted that patients who are in pain often get relief from placebos. The more invasive the procedure, the stronger the placebo effect, he said, perhaps because patients become invested in the idea that an intervention will really help. Even saltwater injections help 70% of patients, Fu said.
A 2016 review in the Journal of Bone and Joint Surgery concluded that “the value and effective use of cell therapy in orthopaedics remain unclear.” The following year, a review in the British Journal of Sports Medicine concluded, “We do not recommend stem cell therapy” for knee arthritis.
Shapiro said hospitals and health plans are right to be cautious.
“The insurance companies don’t pay for fat grafting or bone-marrow aspiration, and rightly so,” Shapiro said. “That’s because we don’t have enough evidence.”
Rickert, an orthopedist in Bedford, Ind., said fat, bone marrow and platelet injections should be offered only through clinical trials, which carefully evaluate experimental treatments. Patients shouldn’t be charged for these services until they’ve been tested and shown to work.
Orthopedists — surgeons who specialize in bones and muscles — have a history of performing unproven procedures, including spinal fusion, surgery for rotator cuff disease and arthroscopy for worn-out knees, Turner said. Recently, studies have shown them to be no more effective than placebos.
Misleading Marketing
Some argue that joint injections shouldn’t be marketed as stem cell treatments at all.
Piuzzi said he prefers to call the injections “orthobiologics,”noting that platelets are not even cells, let alone stem cells. The number of stem cells in fat and bone marrow injections is extremely small, he said. In fat tissue, only about 1 in 2,000 cells is a stem cell, according to a March paper in The Bone & Joint Journal. Stem cells are even rarer in bone marrow, where 1 in 10,000 to 20,000 cells is a stem cell.
Patients are attracted to regenerative medicine because they assume it will regrow their lost cartilage, Piuzzi said. There’s no solid evidence that the commercial injections used today spur tissue growth, Piuzzi said. Although doctors hope that platelets will release anti-inflammatory substances, which could theoretically help calm an inflamed joint, they don’t know why some patients who receive platelet injections feel better, but others don’t.
So, it comes as no surprise that many patients have trouble sorting through the hype.
Florida resident Kathy Walsh, 61, said she wasted nearly $10,000 on stem cell and platelet injections at a Miami clinic, hoping to avoid knee replacement surgery.
When Walsh heard about a doctor in Miami claiming to regenerate knee cartilage with stem cells, “it seemed like an answer to a prayer,” said Walsh, of Stuart, Fla. “You’re so much in pain and so frustrated that you cling to every bit of hope you can get, even if it does cost you a lot of money.”
The injections eased her pain for only a few months. Eventually, she had both knees replaced. She has been nearly pain-free ever since. “My only regret,” she said, “is that I wasted so much time and money.”




Friday, March 2, 2018

These Antidepressant Side-Effects Outweigh Benefits, Study Concludes

Well, antidepressants are known to improve stroke recovery.

Antidepressants may help people recover from stroke even if they are not depressed 

 How is your doctor alleviating these extra risks? 

These Antidepressant Side-Effects Outweigh Benefits, Study Concludes

Millions are prescribed antidepressants each year, but what are they doing to the body?
Antidepressants may do more harm than good, according to a review looking at the drug’s impact on the whole body.
While the drugs may be effective at alleviating depression, they have considerable side-effects.
The researchers found three studies that suggest people taking antidepressants die at a higher rate.
One study has even suggested antidepressants may increase the risk of death by 33%.
Dr Paul Andrews, the study’s first author, said:
“We need to be much more cautious about the widespread use of these drugs.
It’s important because millions of people are prescribed anti-depressants each year, and the conventional wisdom about these drugs is that they’re safe and effective.”
The study found that the side-effects of antidepressants include:
  • Problems with sexual stimulation and function — they also affect sperm development.
  • Digestive problems like constipation, diarrhea, indigestion and bloating. (I had this for the few months I was taking them)
  • Developmental problems in children.
  • Strokes and abnormal bleeding in the elderly.
Many of these processes are regulated by serotonin.
Dr Andrews said:
“Serotonin is an ancient chemical. It’s intimately regulating many different processes, and when you interfere with these things you can expect, from an evolutionary perspective, that it’s going to cause some harm.
The thing that’s been missing in the debates about anti-depressants is an overall assessment of all these negative effects relative to their potential beneficial effects.
Most of this evidence has been out there for years and nobody has been looking at this basic issue.”
Previous studies by Dr Andrews and colleagues have found relatively minimal benefits of antidepressants.
They have also found people were more likely to relapse after taking the drug.
Dr Andrews said:
“It could change the way we think about such major pharmaceutical drugs.
You’ve got a minimal benefit, a laundry list of negative effects — some small, some rare and some not so rare.
The issue is: does the list of negative effects outweigh the minimal benefit?”

The study was published in the journal Frontiers in Psychology (Andrews et al., 2012).

Wednesday, October 11, 2017

Antidepressants Side-Effects Higher Than Previously Thought

With a 33% chance of depression after stroke and the fact that taking antidepressants helps stroke recovery even if not depressed. What the fuck is your doctor doing to handle the competing priorities? I had constipation from antidepressants, got off them because they were incorrectly prescribed. I haven't been depressed a day in my life.

Common antidepressant can help stroke patients improve movement and coordination Sept. 2015 

 

Antidepressants may help people recover from stroke even if they are not depressed Jan. 2013 

 

Antidepressants Side-Effects Higher Than Previously Thought

Antidepressants side-effects: in the US one in ten are prescribed antidepressants each year, but are they told about ALL the side-effects?
A new survey of antidepressants side-effects has found higher than expected levels of emotional numbness, sexual problems and even suicidal thoughts associated with the medication (Read et al., 2014).
The study, published in the journal Psychiatry Research, found that as many as half the people they surveyed had psychological problems due to their medication.
The authors again question whether antidepressants are being over-prescribed.
The paper’s lead author, Professor John Read, said:
“The medicalization of sadness and distress has reached bizarre levels. One in ten people in some countries are now prescribed antidepressants each year.
“While the biological side-effects of antidepressants, such as weight gain and nausea, are well documented, the psychological and interpersonal effects have been largely ignored or denied. They appear to be alarmingly common.”
The study gathered data from 1,829 people from New Zealand who had all taken antidepressants in the last five years.
The questionnaire asked about how they had felt while they were taking their medication.
Of the 20 adverse effects that people were questioned about:
  • 62% said they had ‘sexual difficulties’,
  • 52% said they ‘didn’t feel like themselves’,
  • 42% noticed a ‘reduction in positive feelings’,
  • 39% found themselves ‘caring less about others’,
  • and 55% reported ‘withdrawal effects’.
Set against these findings, though, 82% said that the drugs had been useful in tackling their depression.
The results took into account the fact that people had varying levels of depression.
Professor John Read commented on the results:
“Effects such as feeling emotionally numb and caring less about other people are of major concern. Our study also found that people are not being told about this when prescribed the drugs.
“Our finding that over a third of respondents reported suicidality ‘as a result of taking the antidepressants’ suggests that earlier studies may have underestimated the problem.”

Antidepressants side-effects

These findings come on top of a new review of studies examining patients’ experiences of taking antidepressants (Gibson et al., 2014).
Across the studies reviewed, people consistently reported a…
“…reduction of positive and negative emotions, emotional detachment, a belief that ADs prevent natural sadness, personality changes, harmful effects on relationships, fear of addiction, and suicidality.” (Read et al., 2014; referring to Gibson et al., 2014).
Given these frequently reported antidepressants side-effects, it is incredible how few people are told about them:
“Very few, it seems, are told about the more subtle, but pervasive and potentially demoralizing, effects on one’s ability to feel positive emotions, or to feel anything at all, or about the potential effects on their relationships with other people. The ethical principle of informed choice suggests that this needs to change.” (Read et al., 2014).


Sunday, October 1, 2017

Major breakthrough as doctors REVERSE symptoms of a stroke: Patients to walk, talk and live a normal life after stem cell treatment - up to 3 YEARS later

I'm not sure that this is anything other than placebo. No proof that the stem cells either survived or triggered massive neurogenesis and neuroplasticity.  Did they inform their patients of these possible side effects?

Tumors caused by pluripotent stem cells can be tackled with radiation, say Stanford researchers

 

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

 

He went abroad for stem cell treatment. Now he’s a cautionary tale. Stroke patient Jim Gass

 

“Off-the-charts dangerous”: Sham stem cell trial at Florida clinic blinds three women

 

Stem cell propagation fuels cancer risk in different organs 


http://www.dailymail.co.uk/health/article-3622589/Major-breakthrough-doctors-REVERSE-symptoms-stroke-Patients-walk-talk-live-normal-life-stem-cell-treatment-3-YEARS-later.html

Doctors have reversed the symptoms of stroke in a major medical breakthrough using stem cell treatment, a Stanford University study has shown
Doctors have reversed the symptoms of stroke in a major medical breakthrough using stem cell treatment, a Stanford University study has shown
Doctors have reversed the symptoms of stroke in a major medical breakthrough.
Patients regained the ability to walk, speak and have a normal family life, thanks to a procedure requiring only local anaesthetic and a single night in hospital.
Remarkably, the stem cell treatment was shown to work even three years after someone had suffered a stroke - meaning that millions of people could potentially benefit from the treatment.
Eighteen patients underwent the procedure in an initial trial - with stunning results.
Despite the long gap between stroke and treatment, all 18 patients in the pilot showed increasing improvement for the 12 months they were tracked after the operation.
Nearly half showed ‘clinically meaningful’ results - which meant the procedure had a significant impact on their lifestyle.
One patient who relied on a wheelchair, unable to properly use her legs, has since taken up jogging.
Another woman, who could barely get to her feet before the operation, has since walked down the aisle and is now expecting a baby with her new husband.
And another, completely paralysed apart from the use of her left thumb, has regained the ability to walk.
The treatment, carried out by scientists at Stanford University in California, is thought to be so effective because it triggers the rapid regeneration of brain circuits damaged during a stroke.
There are 1.2million stroke survivors in Britain - many who have never recovered their independence.
More than 150,000 people have a stroke in England every year, with patients suffering paralysis, speech problems and personality changes.
Experts last night stressed that we are several years away from the treatment being rolled out to all stroke patients - because far more testing is needed before the procedure is proven to be completely effective.
The experiment was only set up to establish that the treatment was safe - which it did - but 18 patients are not enough to show that it will work on all people.
But the team has already started on work to replicate their results on a larger scale, and if that is successful the technique has great potential to revolutionise life for stroke patients.
The researchers, whose work was published last night in the Stroke medical journal, tested the treatment on 11 women and seven men, aged 33 to 75.
Each was given stem cells between six months and three years after they suffered a chronic stroke.
Although stem cell treatments have been shown to work for stroke patients in other small trials in the past, most have been given within days of suffering a stroke.
But the new study suggests that the treatment might work for a much longer window - significantly expanding the number of people who might benefit.
Study leader Professor Gary Steinberg said: ‘Patients improved by several standard measures, and their improvement was not only statistically significant, but clinically meaningful.
‘Their ability to move around has recovered visibly. That’s unprecedented. At six months out from a stroke, you don’t expect to see any further recovery.’
The participants remained conscious under local anaesthesia, while a small hole was drilled through their skulls and stem cells injected into the damaged area of their brain.

WOMAN CONFINED TO A WHEELCHAIR AFTER SUFFERING A STROKE AT 31, WALKS DOWN THE AISLE AND IS EXPECTING A BABY WITH HER HUSBAND

Twelve months ago Sonia Coontz proudly strode down the aisle to marry her fiancé Peter.
Just a few months earlier, such a feat would have been unthinkable.
Because Mrs Coontz had been consigned to a wheelchair, the victim of a vicious stroke that had struck when she was just 31.
She survived the stroke, but was left profoundly disabled.
Sonia Coontz suffered a stroke when she was just 31 years old. It left her confined to a wheelchair, unable to walk and profoundly disabled. Mrs Coontz pictured with her husband Peter
Sonia Coontz suffered a stroke when she was just 31 years old. It left her confined to a wheelchair, unable to walk and profoundly disabled. Mrs Coontz pictured with her husband Peter
‘It was very bad,’ Mrs Coontz, now aged 36, said last night, speaking from her home in California.
‘I could not speak well, my left leg did not work very well so I had to use a wheelchair. My right arm was almost dead and my shoulder hurt so badly.’
Two years ago, Mrs Coontz was one of 18 patients to undergo a radical new procedure at Stanford Medical School.
Under local anaesthetic, she received stem cell injections directly into her brain, designed to regenerate the neural circuits left damaged by her stroke.
‘After the surgery instantly all that pain had gone from my shoulder,’ she said. ‘I could move my arm all the way back for the first time.
‘And from that day on I never sat in a wheelchair again.’
Mrs Coontz had been putting off her marriage, too embarrassed at her inability to walk to put herself through the spectacle of a wedding.
‘Last June I was able to walk down the aisle,’ she said. ‘I would not have been able to do that before.
‘And now I’m pregnant - we are expecting a boy in September.
‘Every day I get better. I still have some recovering to do, but I feel terrific.’

Tuesday, August 29, 2017

Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events

See how long before your doctor talks to you about this. I'm guessing years. Be aware of side effects.
http://press.novonordisk-us.com/2017-08-25-Victoza-R-liraglutide-is-approved-in-the-US-as-the-only-type-2-diabetes-treatment-indicated-to-reduce-the-risk-of-three-major-adverse-cardiovascular-events
LAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza® (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events, heart attack, stroke and CV death, in adults with type 2 diabetes and established CV disease.1
The FDA's decision is based on the results from the landmark LEADER trial, which demonstrated that Victoza® significantly reduced the risk of a three component endpoint consisting of cardiovascular death, non-fatal heart attack or non-fatal stroke by 13% vs placebo (p=0.01) with an absolute risk reduction (ARR) of 1.9%.1
"Physicians have come to rely on Victoza® as an effective therapy for lowering A1C, and with this new indication, they now have the option to choose a diabetes medication that also reduces their patient's cardiovascular risk," said Anne Phillips, Senior Vice President, Clinical, Medical and Regulatory Affairs for Novo Nordisk. "This is good news for patients and health care providers that will also bring much needed attention to the relationship between type 2 diabetes and cardiovascular disease."
Cardiovascular disease is the leading cause of morbidity and mortality in patients with diabetes.2 Studies have shown that adults with type 2 diabetes are up to four times more likely to develop cardiovascular disease.3 Victoza® demonstrated a life-saving benefit that included a 22% reduction in cardiovascular death and a 15% reduction in all-cause death (ARR 1.3%, 1.4% respectively).
"Today's news is significant for millions of Americans living with type 2 diabetes because, even when controlled, diabetes puts patients at a greater risk for cardiovascular events," said Steve Marso, MD, Medical Director, Cardiovascular Services HCA Midwest Health Heart and Vascular Institute and one of the primary investigators in LEADER. "More treatment options like Victoza® that address critical aspects of diabetes care beyond glucose lowering are essential to confront this pervasive issue."
About Victoza® Victoza® (liraglutide) is a human glucagon-like peptide-1 (GLP-1) analog that was approved by the U.S. Food and Drug Administration on January 25, 2010, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is commercially available in 95 countries, treating more than 1 million people with type 2 diabetes globally.4
Eligible patients with commercial insurance can use the Victoza® Instant Savings Card to reduce co-pays to as low as $25 a month for up to 48 months. Eligibility and other restrictions apply. For complete terms and conditions and any questions regarding eligibility, visit https://www.victoza.com/content/victoza/en/consider-using-victoza-/save-on-your-prescription.html or call 1-855-292-5966.
About the LEADER trial LEADER was a multicenter, international, randomized, double-blind, placebo-controlled trial investigating the long-term (3.5–5 years) effects of Victoza® (liraglutide) compared to placebo, both in addition to standard of care, in people with type 2 diabetes at high risk of major adverse cardiovascular events. Standard of care was comprised of lifestyle modifications, glucose-lowering treatments and cardiovascular medications.5
The landmark LEADER trial was initiated in September 2010 and randomized 9,340 people with type 2 diabetes from 32 countries. The primary endpoint was the first occurrence of a composite cardiovascular outcome comprised of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke.5
Indication and Usage
What is Victoza®?
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine for adults with type 2 diabetes that:
  • along with diet and exercise may improve blood sugar (glucose).
  • along with your current treatment for your cardiovascular disease may reduce the risk of major cardiovascular events such as heart attack, stroke, or death.
Victoza® is not a substitute for insulin and is not for use in people with type 1 diabetes or people with diabetic ketoacidosis.
It is not known if Victoza® can be used with mealtime insulin.
It is not known if Victoza® is safe and effective for use in children.
Important Safety Information
What is the most important information I should know about Victoza®?
Victoza
® may cause serious side effects, including:
  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza® and medicines that work like Victoza® caused thyroid tumors, including thyroid cancer. It is not known if Victoza® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Who should not use Victoza®? Do not use Victoza® if:
  • you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • you are allergic to liraglutide or any of the ingredients in Victoza®.
What should I tell my health care provider before using Victoza®? Before using Victoza®, tell your health care provider if you:
  • have or have had problems with your pancreas, kidneys, or liver.
  • have any other medical conditions or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed.
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
How should I use Victoza®?
  • Do not mix insulin and Victoza® together in the same injection.
  • You may give an injection of Victoza® and insulin in the same body area (such as your stomach area), but not right next to each other.
  • Do not share your Victoza® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
What are the possible side effects of Victoza®?
Victoza® may cause serious side effects, including:
  • inflammation of your pancreas (pancreatitis). Stop using Victoza® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse.
  • serious allergic reactions. Stop using Victoza® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, or a very rapid heartbeat.
  • gallbladder problems. Gallbladder problems have happened in some people who take Victoza. Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include pain in the right or middle upper stomach area, fever, nausea and vomiting, or your skin or the white part of your eyes turns yellow.
The most common side effects Victoza® may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation.
Please click here for Prescribing Information and Medication Guide.


Monday, April 10, 2017

15 Rx Meds With Some of the Most Dangerous Side Effects

Some of these might be in your health prescriptions, be careful out there. Ambien and Lunesta seemed to be the sleeping aids of choice at the hospital I was at. 
http://www.cheatsheet.com/health-fitness/rx-meds-dangerous-side-effects.html/?ref=YF&yptr=yahoo

1. Yaz

Most people who are on Yaz experience less severe side effects like headaches, nausea, and irritability, but blood clots can be life-threatening.

12. Levaquin or Cipro

According to an FDA safety review, researchers found these antibiotics can greatly affect the tendons, muscles, joints, nerves, and central nervous system. 

13. Brilinta

For some, though, this medication can cause severe bleeding that can even be fatal. 

15. Ambien

It’s also possible the medication’s effects can carry into your day, causing severe drowsiness and impairment in your thinking and reactions. Could this have been part of the reason I could fall asleep in 5 minutes during the day while at the hospital? And the fogginess of my thinking?

 

Tuesday, September 20, 2016

Physical environments and community reintegration post stroke: qualitative insights from stroke clubs

Let's focus on the real problem here, not the side effects. The real problem is disability and the way to vastly reduce disability is to solve  the neuronal cascade of death by these 5 causes in the first week. 
 This does leave existing stroke survivors hanging but that can be solved by figuring out exactly how to encourage neuroplasticity and neurogenesis. These are going to be difficult problems to solve but LEADERS  tackle the hard problems, they don't ignore them!
http://www.tandfonline.com/doi/full/10.1080/09687599.2016.1223606 


Pages 1-17 | Received 09 Dec 2015, Accepted 09 Aug 2016, Published online: 19 Sep 2016
This study investigated the environment’s role in community reintegration amongst persons with experience of stroke. Focus group discussions with 29 individuals recruited from community stroke clubs in Scotland revealed that stroke influenced a person’s perceptions, experience, use and enjoyment of the environment. Multiple specific (e.g. theatres, cafes) and more general (out-of-the-home) environments appeared capable of supporting community reintegration, providing settings in which individuals were able and willing to interact with others and participate in various functional, social and recreational activities. The article reflects on the study’s implications for policy and practice.

Points of interest

• Community reintegration post stroke may be supported by multiple specific (e.g. theatres, parks, the home) and more general (out-of-the-home) environments.
• These can provide settings in which individuals are motivated to interact with others and participate in various functional, social and recreational activities.
• Stroke can have a profound impact on an individual’s perceptions, experience, use and enjoyment of the environment.
• Peer support is valued by, and may bring important benefits to, stroke survivors.

Introduction

There are over 1.2 million stoke survivors in the United Kingdom whilst every year some 152,000 strokes occur, equivalent to one every 3 minutes 27 seconds (Stroke Association 2016 Stroke Association. 2016. State of the Nation – Stroke Statistics. London: Stroke Association.). The prevalence of stroke increased by 12.5% between 1999 and 2008, whilst the incidence of stroke fell by approximately 30% (Lee, Shafe, and Cowie 2011 Lee, Sally, Anna C. E. Shafe, and Martin R. Cowie. 2011. “UK Stroke Incidence, Mortality and Cardiovascular Risk Management 1999–2008: Time-Trend Analysis from the General Practice Research Database.” BMJ Open 1 (2): e000269.[CrossRef]). Improved drug treatment in primary care is likely to be a major contributor to the latter (Lee, Shafe, and Cowie 2011 Lee, Sally, Anna C. E. Shafe, and Martin R. Cowie. 2011. “UK Stroke Incidence, Mortality and Cardiovascular Risk Management 1999–2008: Time-Trend Analysis from the General Practice Research Database.” BMJ Open 1 (2): e000269.[CrossRef], 1). Our ageing population (Mayo et al. 2002 Mayo, Nancy E., Sharon Wood-Dauphinee, Robert Côté, Liam Durcan, and Joseph Carlton. 2002. “Activity, Participation, and Quality of Life 6 Months Poststroke.” Archives of Physical Medicine and Rehabilitation 83 (8): 1035–1042. doi:10.1053/apmr.2002.33984.[CrossRef], [PubMed], [Web of Science ®], [CSA]), with age being the single most important risk factor for stroke (Stroke Association 2016 Stroke Association. 2016. State of the Nation – Stroke Statistics. London: Stroke Association.), combined with developments in acute stroke management and rehabilitation, leading to reduced stroke mortality (Lee, Shafe, and Cowie 2011 Lee, Sally, Anna C. E. Shafe, and Martin R. Cowie. 2011. “UK Stroke Incidence, Mortality and Cardiovascular Risk Management 1999–2008: Time-Trend Analysis from the General Practice Research Database.” BMJ Open 1 (2): e000269.[CrossRef]), mean that an increasing number of people with stroke are now returning to the community (Wood, Connelly, and Maly 2010 Wood, Jennifer P., Denise M. Connelly, and Monica R. Maly. 2010. “‘Getting back to Real Living’: A Qualitative Study of the Process of Community Reintegration after Stroke.” Clinical Rehabilitation 24 (11): 1045–1056. doi:10.1177/0269215510375901.[CrossRef], [PubMed], [Web of Science ®]).
In the context of stroke, community reintegration can be defined as a person’s return to everyday functional activities, instrumental activities of daily living, recreational and social activities, and interactions with family members and others (Pang, Eng, and Miller 2007 Pang, Marco Y. C., Janice J. Eng, and William C. Miller. 2007. “Determinants of Satisfaction with Community Reintegration in Older Adults with Chronic Stroke: Role of Balance Self-Efficacy.” Physical Therapy 87 (3): 282–291. doi:10.2522/ptj.20060142.[CrossRef], [PubMed], [Web of Science ®]). It is, therefore, a relatively broad concept concerned with participation in various life domains. We focus here on community reintegration because evidence suggests it captures processes which are important to stroke survivors (although no judgement is passed on whether or why these processes should be considered important) (Bergström et al. 2015 Bergström, A. L., L. von Koch, M. Andersson, K. Tham, and G. Eriksson. 2015. “Participation in Everyday Life and Life Satisfaction in Persons with Stroke and Their Caregivers 3–6 Months after Onset.” Journal of Rehabilitation Medicine 47 (6): 508–515. doi: 10.2340/16501977-1964.[CrossRef], [PubMed], [Web of Science ®]; Wood, Connelly, and Maly 2010 Wood, Jennifer P., Denise M. Connelly, and Monica R. Maly. 2010. “‘Getting back to Real Living’: A Qualitative Study of the Process of Community Reintegration after Stroke.” Clinical Rehabilitation 24 (11): 1045–1056. doi:10.1177/0269215510375901.[CrossRef], [PubMed], [Web of Science ®]). That poor community reintegration has been associated with depression, social isolation, a poor quality of life (Wood, Connelly, and Maly 2010 Wood, Jennifer P., Denise M. Connelly, and Monica R. Maly. 2010. “‘Getting back to Real Living’: A Qualitative Study of the Process of Community Reintegration after Stroke.” Clinical Rehabilitation 24 (11): 1045–1056. doi:10.1177/0269215510375901.[CrossRef], [PubMed], [Web of Science ®]) and reduced life satisfaction (Astrom, Asplund, and Astrom 1992 Astrom, M., Kjell Asplund, and T. Astrom. 1992. “Psychosocial Function and Life Satisfaction after Stroke.” Stroke 23 (4): 527–531.10.1161/01.STR.23.4.527[CrossRef], [PubMed], [Web of Science ®]) underlines its importance.
Community reintegration is, of course, neither an unproblematic nor an uncontested concept (Myers et al. 1998 Myers, Fiona, Alastair Ager, Patricia Kerr, and Susan Myles. 1998. “Outside Looking in? Studies of the Community Integration of People with Learning Disabilities.” Disability & Society 13 (3): 389–413. doi:10.1080/09687599826704.[Taylor & Francis Online], [Web of Science ®], [CSA]; Mirza et al. 2008 Mirza, Mansha, Andrea Gossett, Nathan Kai-Cheong Chan, Larry Burford, and Joy Hammel. 2008. “Community Reintegration for People with Psychiatric Disabilities: Challenging Systemic Barriers to Service Provision and Public Policy through Participatory Action Research.” Disability & Society 23 (4): 323–336. doi:10.1080/09687590802038829.[Taylor & Francis Online], [Web of Science ®]; van de Ven et al. 2005 van de Ven, Leontine, Marcel Post, Luc de Witte, and Wim van den Heuvel. 2005. “It Takes Two to Tango: The Integration of People with Disabilities into Society.” Disability & Society 20 (3): 311–329. doi:10.1080/09687590500060778.[Taylor & Francis Online], [Web of Science ®]). Some, for instance, might take exception to its implicit support for ‘normalisation’, a concept concerned with how disabled people can ‘slot’ into ‘everyday living’ and lead an ‘ordinary life’ (King’s Fund Centre 1980, 1988 King’s Fund Centre. 1980. An Ordinary Life: Comprehensive Locally-Based Residential Services for Mentally Handicapped People. London: King’s Fund Centre.
King’s Fund Centre. 1988. Ties and Connections: An Ordinary Community Life for People with Learning Difficulties. London: King’s Fund Centre.
). Popular in the 1980s, this concept has since been criticised for overlooking the social construction, and socially constructed meanings, of ‘disability’ and ‘normality’ (Chappell 1992 Chappell, Anne Louise. 1992. “Towards a Sociological Critique of the Normalisation Principle.” Disability, Handicap & Society 7 (1): 35–51. doi:10.1080/02674649266780041.[Taylor & Francis Online]); indeed, by not focusing on deconstructing the meanings attached to disability, writers from critical disability studies may argue that it misses that which should ground our approach to disability (Corker 1999 Corker, Mairian. 1999. “Differences, Conflations and Foundations: The Limits to ‘Accurate’ Theoretical Representation of Disabled People’s Experience?” Disability & Society 14 (5): 627–642. doi:10.1080/09687599925984.[Taylor & Francis Online], [Web of Science ®], [CSA]; Vehmas and Watson 2014 Vehmas, Simo, and Nick Watson. 2014. “Moral Wrongs, Disadvantages, and Disability: A Critique of Critical Disability Studies.” Disability & Society 29 (4): 638–650. doi:10.1080/09687599.2013.831751.[Taylor & Francis Online], [Web of Science ®]). It has also been accused of ignoring the material constraints that impact the lives of disabled people, problematizing rather than valuing difference, and requiring individuals to ‘fit in’ to an unchanged society rather than requiring a changed society to be ‘fit for’ the individual (Chappell 1992 Chappell, Anne Louise. 1992. “Towards a Sociological Critique of the Normalisation Principle.” Disability, Handicap & Society 7 (1): 35–51. doi:10.1080/02674649266780041.[Taylor & Francis Online]; Myers et al. 1998 Myers, Fiona, Alastair Ager, Patricia Kerr, and Susan Myles. 1998. “Outside Looking in? Studies of the Community Integration of People with Learning Disabilities.” Disability & Society 13 (3): 389–413. doi:10.1080/09687599826704.[Taylor & Francis Online], [Web of Science ®], [CSA]; Pothier and Devlin 2006 Pothier, D., and R. Devlin, eds. 2006. Critical Disability Theory: Essays in Philosophy, Politics, Policy, and Law. Vancouver: UBC Press.; Vehmas and Watson 2014 Vehmas, Simo, and Nick Watson. 2014. “Moral Wrongs, Disadvantages, and Disability: A Critique of Critical Disability Studies.” Disability & Society 29 (4): 638–650. doi:10.1080/09687599.2013.831751.[Taylor & Francis Online], [Web of Science ®]; Ward 1992 Ward, L. 1992. “Foreword.” In Normalisation: A Reader, edited by Hilary Brown and Helen Smith, x–xi. Abingdon: Routledge.).
Such concerns aside, given the apparent importance of community reintegration to stroke survivors it is troubling that so many find it difficult and challenging (Pang, Eng, and Miller 2007 Pang, Marco Y. C., Janice J. Eng, and William C. Miller. 2007. “Determinants of Satisfaction with Community Reintegration in Older Adults with Chronic Stroke: Role of Balance Self-Efficacy.” Physical Therapy 87 (3): 282–291. doi:10.2522/ptj.20060142.[CrossRef], [PubMed], [Web of Science ®]; Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]; Wood, Connelly, and Maly 2010 Wood, Jennifer P., Denise M. Connelly, and Monica R. Maly. 2010. “‘Getting back to Real Living’: A Qualitative Study of the Process of Community Reintegration after Stroke.” Clinical Rehabilitation 24 (11): 1045–1056. doi:10.1177/0269215510375901.[CrossRef], [PubMed], [Web of Science ®]). A study with 434 stroke survivors interviewed 6 months post stroke found that 39% reported a limitation in self-care (bathing, dressing, grooming and feeding), 20% reported difficulties in walking and negotiating stairs, 54% reported limitations with instrumental activities of daily living (e.g. housework, shopping and preparing a meal) and 65% reported restrictions in reintegration into community activities (e.g. social and recreational activities, moving around the community and having an important activity to fill the day) (Mayo et al. 2002 Mayo, Nancy E., Sharon Wood-Dauphinee, Robert Côté, Liam Durcan, and Joseph Carlton. 2002. “Activity, Participation, and Quality of Life 6 Months Poststroke.” Archives of Physical Medicine and Rehabilitation 83 (8): 1035–1042. doi:10.1053/apmr.2002.33984.[CrossRef], [PubMed], [Web of Science ®], [CSA]). A study with 105 stroke survivors found that, between three and six months post stroke, 83% perceived restrictions in their participation in everyday occupations, defined as activities people need and want to do, such as household chores, work or work-related activities, travel, leisure and social activities (Bergström et al. 2015 Bergström, A. L., L. von Koch, M. Andersson, K. Tham, and G. Eriksson. 2015. “Participation in Everyday Life and Life Satisfaction in Persons with Stroke and Their Caregivers 3–6 Months after Onset.” Journal of Rehabilitation Medicine 47 (6): 508–515. doi: 10.2340/16501977-1964.[CrossRef], [PubMed], [Web of Science ®]).
Suggestive of the status and influence of the medical model of disability (Brandon and Pritchard 2011 Brandon, Toby, and Gary Pritchard. 2011. “‘Being Fat’: A Conceptual Analysis Using Three Models of Disability.” Disability & Society 26 (1): 79–92. doi:10.1080/09687599.2011.529669.[Taylor & Francis Online], [Web of Science ®]; Schuelka 2015 Schuelka, Matthew J. 2015. “The Evolving Construction and Conceptualisation of ‘Disability’ in Bhutan.” Disability & Society 30 (6): 820–833. doi:10.1080/09687599.2015.1052043.[Taylor & Francis Online], [Web of Science ®]), studies have considered the role of various person-related factors in aiding and/or impeding community reintegration including physical function (Carter et al. 2000 Carter, Bob S., Diedre Buckley, Regina Ferraro, Guy Rordorf, and Christopher S. Ogilvy. 2000. “Factors Associated with Reintegration to Normal Living after Subarachnoid Hemorrhage.” Neurosurgery 46 (6): 1326–1334.10.1097/00006123-200006000-00008[CrossRef], [PubMed], [Web of Science ®]; Ostir et al. 2005 Ostir, Glenn V, Pamela M Smith, David Smith, and Kenneth J Ottenbacher. 2005. “Functional Status and Satisfaction with Community Participation in Persons with Stroke following Medical Rehabilitation.” Aging Clinical and Experimental Research 17 (1): 35–41. doi:10.1007/BF03337718.[CrossRef], [PubMed], [Web of Science ®]), mental health (Carter et al. 2000 Carter, Bob S., Diedre Buckley, Regina Ferraro, Guy Rordorf, and Christopher S. Ogilvy. 2000. “Factors Associated with Reintegration to Normal Living after Subarachnoid Hemorrhage.” Neurosurgery 46 (6): 1326–1334.10.1097/00006123-200006000-00008[CrossRef], [PubMed], [Web of Science ®]), cognitive ability (Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]), self-efficacy (Pang, Eng, and Miller 2007 Pang, Marco Y. C., Janice J. Eng, and William C. Miller. 2007. “Determinants of Satisfaction with Community Reintegration in Older Adults with Chronic Stroke: Role of Balance Self-Efficacy.” Physical Therapy 87 (3): 282–291. doi:10.2522/ptj.20060142.[CrossRef], [PubMed], [Web of Science ®]) and self-awareness (Leung and Liu 2011 Leung, Daniel P. K., and Karen P. Y. Liu. 2011. “Review of Self-Awareness and Its Clinical Application in Stroke Rehabilitation.” International Journal of Rehabilitation Research 34 (3): 187–195.10.1097/MRR.0b013e3283487f31[CrossRef], [PubMed], [Web of Science ®]). Certain factors external to the individual, including social and professional support, have also attracted a degree of attention (Chau et al. 2009 Chau, Janita, David Thompson, Sheila Twinn, Anne Chang, and Jean Woo. 2009. “Determinants of Participation Restriction among Community Dwelling Stroke Survivors: A Path Analysis.” BMC Neurology 9 (49). doi: 10.1186/1471-2377-9-49.10.1186/1471-2377-9-49[CrossRef], [PubMed], [Web of Science ®]; Ellis-Hill et al. 2009 Ellis-Hill, C., J. Robison, R. Wiles, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Going Home to Get on with Life: Patients and Carers Experiences of Being Discharged from Hospital following a Stroke.” Disability & Rehabilitation 31 (2): 61–72.10.1080/09638280701775289[Taylor & Francis Online], [Web of Science ®]; Nicholson et al. 2013 Nicholson, Sarah, Falko F. Sniehotta, Frederike van Wijck, Carolyn A. Greig, Marie Johnston, Marion E. T. McMurdo, Martin Dennis, and Gillian E. Mead. 2013. “A Systematic Review of Perceived Barriers and Motivators to Physical Activity after Stroke.” International Journal of Stroke 8 (5): 357–364.10.1111/ijs.2013.8.issue-5[CrossRef], [PubMed], [Web of Science ®]; Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]; Walsh et al. 2014 Walsh, Mary E., Rose Galvin, Cliona Loughnane, Chris Macey, and N. Frances Horgan. 2014. “Factors Associated with Community Reintegration in the First Year after Stroke: A Qualitative Meta-Synthesis.” Disability and Rehabilitation 37 (18): 1–10. doi:10.3109/09638288.2014.974834.[Taylor & Francis Online], [Web of Science ®]). Compared with these factors, the physical environment – defined here as the objective and perceived qualities and characteristics of the physical settings in which individuals spend time (Van Van Cauwenberg et al. 2011 Van Cauwenberg, Jelle, Ilse De De Bourdeaudhuij, Femke De De Meester, Delfien Van Van Dyck, Jo Salmon Salmon, Peter Clarys, and Benedicte Deforche. 2011. “Relationship between the Physical Environment and Physical Activity in Older Adults: A Systematic Review.” Health & Place 17 (2): 458–469. doi:10.1016/j.healthplace.2010.11.010.[CrossRef], [PubMed], [Web of Science ®]) – although pertinent (Lord and Rochester 2005 Lord, Susan E., and Lynn Rochester. 2005. “Measurement of Community Ambulation after Stroke Current Status and Future Developments.” Stroke 36 (7): 1457–1461.10.1161/01.STR.0000170698.20376.2e[CrossRef], [PubMed], [Web of Science ®]), appears critically understudied.
On the relevance of the physical environment, home modifications and equipment have been identified as valuable to stroke survivors (Gustafsson and Bootle 2013 Gustafsson, L., and K. Bootle. 2013. “Client and Carer Experience of Transition Home from Inpatient Stroke Rehabilitation.” Disability and Rehabilitation 35 (16): 1380–1386.10.3109/09638288.2012.740134[Taylor & Francis Online], [Web of Science ®]; Schulz et al. 2012 Schulz, Celia H., Gayle I. Hersch, Jessica L. Foust, Alicia L. Wyatt, Kyler M. Godwin, Salimah Virani, and Sharon K. Ostwald. 2012. “Identifying Occupational Performance Barriers of Stroke Survivors: Utilization of a Home Assessment.” Physical & Occupational Therapy in Geriatrics 30 (2): 109–123.10.3109/02703181.2012.687441[Taylor & Francis Online]) whilst returning to the familiar home environment is recognised as a key milestone in recovery and a major source of motivation (Wood, Connelly, and Maly 2010 Wood, Jennifer P., Denise M. Connelly, and Monica R. Maly. 2010. “‘Getting back to Real Living’: A Qualitative Study of the Process of Community Reintegration after Stroke.” Clinical Rehabilitation 24 (11): 1045–1056. doi:10.1177/0269215510375901.[CrossRef], [PubMed], [Web of Science ®]). Studies suggest that stroke survivors view the home as a safe place, an environment in which they feel comfortable and confident (Reed et al. 2012 Reed, Mary Catherine, Victorine Wood, Rachel Harrington, and Jane Paterson. 2012. “Developing Stroke Rehabilitation and Community Services: A Meta-Synthesis of Qualitative Literature.” Disability & Rehabilitation 34 (7): 553–563.10.3109/09638288.2011.613511[Taylor & Francis Online], [Web of Science ®]). However, within the home, narrow doorways, stairs, absent handrails, heavy doors and limited space have been found to complicate movement, with poorly designed baths, showers and toilets impeding washing and personal care (Brookfield et al. 2015 Brookfield, Katherine, Claire Fitzsimons, Iain Scott, Gillian Mead, John Starr, Neil Thin, Anthea Tinker, and Catharine Ward Ward Thompson. 2015. “The Home as Enabler of More Active Lifestyles among Older People.” Building Research & Information 43 (5): 616–630. doi:10.1080/09613218.2015.1045702.[Taylor & Francis Online], [Web of Science ®]; Reid 2004 Reid, Denise. 2004. “Accessibility and Usability of the Physical Housing Environment of Seniors with Stroke.” International Journal of Rehabilitation Research 27 (3): 203–208.10.1097/00004356-200409000-00005[CrossRef], [PubMed], [Web of Science ®]; Schulz et al. 2012 Schulz, Celia H., Gayle I. Hersch, Jessica L. Foust, Alicia L. Wyatt, Kyler M. Godwin, Salimah Virani, and Sharon K. Ostwald. 2012. “Identifying Occupational Performance Barriers of Stroke Survivors: Utilization of a Home Assessment.” Physical & Occupational Therapy in Geriatrics 30 (2): 109–123.10.3109/02703181.2012.687441[Taylor & Francis Online]). Outside the home, uneven surfaces and absent handrails have been found to contribute to trips and falls (Reid 2004 Reid, Denise. 2004. “Accessibility and Usability of the Physical Housing Environment of Seniors with Stroke.” International Journal of Rehabilitation Research 27 (3): 203–208.10.1097/00004356-200409000-00005[CrossRef], [PubMed], [Web of Science ®]) and/or a fear of falling (Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]). Either may slow a person’s walking pace (Lennon et al. 2013 Lennon, Olive C., Catherine Doody, Cliodhna Ni Ni Choisdealbh, and Catherine Blake. 2013. “Barriers to Healthy-Lifestyle Participation in Stroke: Consumer Participation in Secondary Prevention Design.” International Journal of Rehabilitation Research 36 (4): 354–361.10.1097/MRR.0b013e3283643d48[CrossRef], [PubMed], [Web of Science ®]) and/or influence an individual’s willingness to go outside (Barnsley, McCluskey, and Middleton 2012 Barnsley, Lara, Annie McCluskey, and Sandy Middleton. 2012. “What People Say about Travelling Outdoors after Their Stroke: A Qualitative Study.” Australian Occupational Therapy Journal 59 (1): 71–78. doi:10.1111/j.1440-1630.2011.00935.x.[CrossRef], [PubMed], [Web of Science ®]; Lennon et al. 2013 Lennon, Olive C., Catherine Doody, Cliodhna Ni Ni Choisdealbh, and Catherine Blake. 2013. “Barriers to Healthy-Lifestyle Participation in Stroke: Consumer Participation in Secondary Prevention Design.” International Journal of Rehabilitation Research 36 (4): 354–361.10.1097/MRR.0b013e3283643d48[CrossRef], [PubMed], [Web of Science ®]; Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]). Indeed, research suggests that stroke survivors can consciously adapt their participation in valued activities in response to perceived/experienced environmental limitations (Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]). Highlighted by several of these examples, where research has considered the physical environment, attention has often focused on how it might frustrate community reintegration.
Taking a different tack, in this study the physical environment was conceived as a potentially positive resource capable of supporting community reintegration by providing settings in which individuals can, perhaps are encouraged to, interact with others and undertake various functional, social and recreational activities. Several factors structured this conceptualisation. First, findings from non-stroke populations which suggest that certain environmental details are associated with participation in the community and everyday activities were noted. For example, proximity to recreational facilities has been linked to participation in recreational physical activity in older adults (Berke et al. 2006 Berke, Ethan M., Ronald T. Ackermann, Elizabeth H. Lin, Paula H. Diehr, Matthew L. Maciejewski, Barbara Williams, Marcia B. Patrick, and James P. LoGerfo. 2006. “Distance as a Barrier to Using a Fitness-Program Benefit for Managed Medicare Enrollees.” Journal of Aging and Physical Activity 14 (3): 313–324.10.1123/japa.14.3.313[CrossRef], [PubMed], [Web of Science ®]) whilst proximity to retail facilities has been linked to recreational walking (Michael et al. 2006 Michael, Y., T. Beard, D. Choi, S. Farquhar, and N. Carlson. 2006. “Measuring the Influence of Built Neighborhood Environments on Walking in Older Adults.” Journal of Aging and Physical Activity 14 (3): 302.10.1123/japa.14.3.302[CrossRef], [PubMed], [Web of Science ®]).
Second, models of disability which, whilst diverse, share the view that the physical environment influences participation and the performance of everyday activities were considered. This included the biopsychosocial model of disability, which views disability as the outcome of an interactive relationship between intrinsic features of the human body and features of the external environment (Bickenbach 2012 Bickenbach, Jerome. 2012. “Ethics, Disability and the International Classification of Functioning, Disability and Health.” American Journal of Physical Medicine & Rehabilitation 91 (13): S163–S167. doi:10.1097/PHM.0b013e31823d5487.[CrossRef], [PubMed], [Web of Science ®], S164–S165), and the social model, which understands disability as a form of social oppression produced by physical, social and economic factors/structures external to the individual (Tregaskis 2002 Tregaskis, Claire. 2002. “Social Model Theory: The Story So Far ….” Disability & Society 17 (4): 457–470. doi:10.1080/09687590220140377.[Taylor & Francis Online], [Web of Science ®], [CSA]).
Third, theories from environmental psychology which suggest that individuals are inclined to ‘approach’ – enter, explore, be satisfied with and interact with others within – ‘pleasing’ environments were considered (De Nisco and Warnaby 2014 De Nisco, Alessandro, and Gary Warnaby. 2014. “Urban Design and Tenant Variety Influences on Consumers’ Emotions and Approach Behavior.” Journal of Business Research 67 (2): 211–217. doi:10.1016/j.jbusres.2012.10.002.[CrossRef], [Web of Science ®]; Donovan et al. 1994 Donovan, Robert J., John R. Rossiter, Gilian Marcoolyn, and Andrew Nesdale. 1994. “Store Atmosphere and Purchasing Behavior.” Journal of Retailing 70 (3): 283–294. doi:10.1016/0022-4359(94)90037-X.[CrossRef], [Web of Science ®]; Mehrabian and Russell 1974 Mehrabian, Albert, and James A. Russell. 1974. An Approach to Environmental Psychology. Cambridge, MA: The MIT Press.[CrossRef]; Vieira 2013 Vieira, Valter Afonso. 2013. “Stimuli–Organism-Response Framework: A Meta-Analytic Review in the Store Environment.” Journal of Business Research 66 (9): 1420–1426. doi:10.1016/j.jbusres.2012.05.009.[CrossRef], [Web of Science ®]). Additionally, research which suggests that stroke survivors limit their contact with environments/environmental factors experienced or perceived as ‘problematic’ was noted (Brookfield et al. 2015 Brookfield, Katherine, Claire Fitzsimons, Iain Scott, Gillian Mead, John Starr, Neil Thin, Anthea Tinker, and Catharine Ward Ward Thompson. 2015. “The Home as Enabler of More Active Lifestyles among Older People.” Building Research & Information 43 (5): 616–630. doi:10.1080/09613218.2015.1045702.[Taylor & Francis Online], [Web of Science ®]; Gustafsson and Bootle 2013 Gustafsson, L., and K. Bootle. 2013. “Client and Carer Experience of Transition Home from Inpatient Stroke Rehabilitation.” Disability and Rehabilitation 35 (16): 1380–1386.10.3109/09638288.2012.740134[Taylor & Francis Online], [Web of Science ®]; Robison et al. 2009 Robison, J., R. Wiles, C. Ellis-Hill, K. McPherson, D. Hyndman, and A. Ashburn. 2009. “Resuming Previously Valued Activities Post-Stroke: Who or What Helps?” Disability and Rehabilitation 31 (19): 1555–1566. doi:10.1080/09638280802639327.[Taylor & Francis Online], [Web of Science ®]).
Lastly, the conceptualisation was influenced by research from Barnsley, McCluskey, and Middleton (2012 Barnsley, Lara, Annie McCluskey, and Sandy Middleton. 2012. “What People Say about Travelling Outdoors after Their Stroke: A Qualitative Study.” Australian Occupational Therapy Journal 59 (1): 71–78. doi:10.1111/j.1440-1630.2011.00935.x.[CrossRef], [PubMed], [Web of Science ®]) which found that stroke survivors with ‘meaningful destinations’, places such as pubs, clubs and shopping centres that individuals wished to visit, were more likely to travel outdoors.
Set against this background, the research aimed to identify the environments/environmental factors enjoyed by persons with experience of stroke, whilst not presupposing that these would differ from those enjoyed by anyone else, in order to tease out qualitative insights into the environment’s role in community reintegration. A deeper understanding of the physical environment’s place in community reintegration may lead to the identification of new and effective ways to support stroke survivors to lead self-directed lives of their choosing in the community.